MD - MEDNAX, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
3,688,916
3,647,123
3,458,312
3,183,159
Cost of Revenue
2,689,190
2,657,616
2,458,252
2,149,636
Gross Profit
969,042
989,507
1,000,060
1,033,523
Operating Expenses
Research Development
-
-
-
-
Selling General and Administrative
441,693
432,378
417,105
372,572
Total Operating Expenses
550,025
543,659
519,984
461,836
Operating Income or Loss
419,017
445,848
480,076
571,687
Interest Expense
117,132
88,769
74,559
63,092
Total Other Income/Expenses Net
-1,487,534
11,760
4,905
5,204
Income Before Tax
-1,185,649
368,839
410,422
513,799
Income Tax Expense
-74,252
100,210
90,050
189,203
Income from Continuing Operations
-1,111,397
268,629
320,372
324,596
Net Income
-1,446,819
268,629
320,372
324,914
Net Income available to common shareholders
-1,446,819
268,629
320,372
324,914
Reported EPS
Basic
-
3.06
3.42
3.47
Diluted
-
2.93
3.42
3.47
Weighted average shares outstanding
Basic
-
87,820
93,721
93,718
Diluted
-
91,606
93,721
93,718
EBITDA
-
568,889
587,860
666,155